 | • レポートコード：MRC2-11QY04012 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は非ステロイド性抗炎症薬（NSAID）のグローバル市場について調査・分析したレポートです。種類別（パラセタモール、イブプロフェン、アスピリン、ナプロキセン、その他）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別非ステロイド性抗炎症薬（NSAID）の競争状況、市場シェア ・世界の非ステロイド性抗炎症薬（NSAID）市場：種類別市場規模 2015年-2020年（パラセタモール、イブプロフェン、アスピリン、ナプロキセン、その他） ・世界の非ステロイド性抗炎症薬（NSAID）市場：種類別市場規模予測 2021年-2026年（パラセタモール、イブプロフェン、アスピリン、ナプロキセン、その他） ・世界の非ステロイド性抗炎症薬（NSAID）市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、オンライン薬局） ・世界の非ステロイド性抗炎症薬（NSAID）市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、オンライン薬局） ・北米の非ステロイド性抗炎症薬（NSAID）市場分析：米国、カナダ ・ヨーロッパの非ステロイド性抗炎症薬（NSAID）市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの非ステロイド性抗炎症薬（NSAID）市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の非ステロイド性抗炎症薬（NSAID）市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの非ステロイド性抗炎症薬（NSAID）市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Novartis、Pfizer、Boehringer Ingelheim、Teva Pharmaceutical、Hospira、Lonza Group、Mylan、Aurobindo Pharma、Dr. Reddy's Laboratories、Actavis、Wuxi Apptec、Zhejiang NHU ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and kidney disease.
North America dominated the global NSAID API market due to high demand for APIs in drug formulations and research and development programs in this region. The region is expected to continue its dominance in the coming years owing to increasing preference for generic medicines as a result of high healthcare costs in the U.S. Among other regions, Asia-Pacific is the next largest market for APIs. This region has become the most attractive market due to clustering of a large number of generic medicine manufacturers.
Market Analysis and Insights: Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market
The global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Scope and Market Size
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Novartis
Pfizer
Boehringer Ingelheim
Teva Pharmaceutical
Hospira
Lonza Group
Mylan
Aurobindo Pharma
Dr. Reddy’s Laboratories
Actavis
Wuxi Apptec
Zhejiang NHU
Market segment by Type, the product can be split into
Paracetamol
Ibuprofen
Aspirin
Naproxen
Others
Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue
1.4 Market by Type
1.4.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Paracetamol
1.4.3 Ibuprofen
1.4.4 Aspirin
1.4.5 Naproxen
1.4.6 Others
1.5 Market by Application
1.5.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Perspective (2015-2026)
2.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Growth Trends by Regions
2.2.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Share by Regions (2015-2020)
2.2.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Growth Strategy
2.3.6 Primary Interviews with Key Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players by Market Size
3.1.1 Global Top Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players by Revenue (2015-2020)
3.1.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Players (2015-2020)
3.1.3 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Ratio
3.2.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in 2019
3.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Players Head office and Area Served
3.4 Key Players Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Solution and Service
3.5 Date of Enter into Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Size by Type (2015-2020)
4.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020)
5.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020)
6.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in North America (2019-2020)
6.3 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020)
6.4 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020)
7 Europe
7.1 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020)
7.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in Europe (2019-2020)
7.3 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020)
7.4 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020)
8 China
8.1 China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020)
8.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in China (2019-2020)
8.3 China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020)
8.4 China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020)
9 Japan
9.1 Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020)
9.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in Japan (2019-2020)
9.3 Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020)
9.4 Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020)
10.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020)
10.4 Southeast Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020)
11 India
11.1 India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020)
11.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in India (2019-2020)
11.3 India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020)
11.4 India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020)
12.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in Central & South America (2019-2020)
12.3 Central & South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020)
12.4 Central & South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Novartis
13.1.1 Novartis Company Details
13.1.2 Novartis Business Overview
13.1.3 Novartis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
13.1.4 Novartis Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020))
13.1.5 Novartis Recent Development
13.2 Pfizer
13.2.1 Pfizer Company Details
13.2.2 Pfizer Business Overview
13.2.3 Pfizer Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
13.2.4 Pfizer Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
13.2.5 Pfizer Recent Development
13.3 Boehringer Ingelheim
13.3.1 Boehringer Ingelheim Company Details
13.3.2 Boehringer Ingelheim Business Overview
13.3.3 Boehringer Ingelheim Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
13.3.4 Boehringer Ingelheim Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
13.3.5 Boehringer Ingelheim Recent Development
13.4 Teva Pharmaceutical
13.4.1 Teva Pharmaceutical Company Details
13.4.2 Teva Pharmaceutical Business Overview
13.4.3 Teva Pharmaceutical Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
13.4.4 Teva Pharmaceutical Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
13.4.5 Teva Pharmaceutical Recent Development
13.5 Hospira
13.5.1 Hospira Company Details
13.5.2 Hospira Business Overview
13.5.3 Hospira Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
13.5.4 Hospira Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
13.5.5 Hospira Recent Development
13.6 Lonza Group
13.6.1 Lonza Group Company Details
13.6.2 Lonza Group Business Overview
13.6.3 Lonza Group Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
13.6.4 Lonza Group Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
13.6.5 Lonza Group Recent Development
13.7 Mylan
13.7.1 Mylan Company Details
13.7.2 Mylan Business Overview
13.7.3 Mylan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
13.7.4 Mylan Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
13.7.5 Mylan Recent Development
13.8 Aurobindo Pharma
13.8.1 Aurobindo Pharma Company Details
13.8.2 Aurobindo Pharma Business Overview
13.8.3 Aurobindo Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
13.8.4 Aurobindo Pharma Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
13.8.5 Aurobindo Pharma Recent Development
13.9 Dr. Reddy’s Laboratories
13.9.1 Dr. Reddy’s Laboratories Company Details
13.9.2 Dr. Reddy’s Laboratories Business Overview
13.9.3 Dr. Reddy’s Laboratories Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
13.9.4 Dr. Reddy’s Laboratories Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
13.9.5 Dr. Reddy’s Laboratories Recent Development
13.10 Actavis
13.10.1 Actavis Company Details
13.10.2 Actavis Business Overview
13.10.3 Actavis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
13.10.4 Actavis Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
13.10.5 Actavis Recent Development
13.11 Wuxi Apptec
10.11.1 Wuxi Apptec Company Details
10.11.2 Wuxi Apptec Business Overview
10.11.3 Wuxi Apptec Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
10.11.4 Wuxi Apptec Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
10.11.5 Wuxi Apptec Recent Development
13.12 Zhejiang NHU
10.12.1 Zhejiang NHU Company Details
10.12.2 Zhejiang NHU Business Overview
10.12.3 Zhejiang NHU Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
10.12.4 Zhejiang NHU Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
10.12.5 Zhejiang NHU Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Market Segments
Table 2. Key Players Covered: Ranking by Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue
Table 3. Ranking of Global Top Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Paracetamol
Table 6. Key Players of Ibuprofen
Table 7. Key Players of Aspirin
Table 8. Key Players of Naproxen
Table 9. Key Players of Others
Table 10. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Regions (2015-2020)
Table 14. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Growth Strategy
Table 20. Main Points Interviewed from Key Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players
Table 21. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Players (2015-2020) (Million US$)
Table 22. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Players (2015-2020)
Table 23. Global Top Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) as of 2019)
Table 24. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Solution and Service
Table 27. Date of Enter into Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) (Million US$)
Table 30. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Share by Type (2015-2020)
Table 31. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type (2021-2026)
Table 32. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Share by Application (2015-2020)
Table 33. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) (Million US$)
Table 34. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Share by Application (2021-2026)
Table 35. North America Key Players Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share (2019-2020)
Table 37. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) (Million US$)
Table 38. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2015-2020)
Table 39. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) (Million US$)
Table 40. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2015-2020)
Table 41. Europe Key Players Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share (2019-2020)
Table 43. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2015-2020)
Table 45. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2015-2020)
Table 47. China Key Players Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (2019-2020) (Million US$)
Table 48. China Key Players Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share (2019-2020)
Table 49. China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) (Million US$)
Table 50. China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2015-2020)
Table 51. China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) (Million US$)
Table 52. China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2015-2020)
Table 53. Japan Key Players Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share (2019-2020)
Table 55. Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2015-2020)
Table 57. Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share (2019-2020)
Table 61. Southeast Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2015-2020)
Table 63. Southeast Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2015-2020)
Table 65. India Key Players Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (2019-2020) (Million US$)
Table 66. India Key Players Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share (2019-2020)
Table 67. India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) (Million US$)
Table 68. India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2015-2020)
Table 69. India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) (Million US$)
Table 70. India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share (2019-2020)
Table 73. Central & South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2015-2020)
Table 75. Central & South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2015-2020)
Table 77. Novartis Company Details
Table 78. Novartis Business Overview
Table 79. Novartis Product
Table 80. Novartis Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$)
Table 81. Novartis Recent Development
Table 82. Pfizer Company Details
Table 83. Pfizer Business Overview
Table 84. Pfizer Product
Table 85. Pfizer Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$)
Table 86. Pfizer Recent Development
Table 87. Boehringer Ingelheim Company Details
Table 88. Boehringer Ingelheim Business Overview
Table 89. Boehringer Ingelheim Product
Table 90. Boehringer Ingelheim Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$)
Table 91. Boehringer Ingelheim Recent Development
Table 92. Teva Pharmaceutical Company Details
Table 93. Teva Pharmaceutical Business Overview
Table 94. Teva Pharmaceutical Product
Table 95. Teva Pharmaceutical Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$)
Table 96. Teva Pharmaceutical Recent Development
Table 97. Hospira Company Details
Table 98. Hospira Business Overview
Table 99. Hospira Product
Table 100. Hospira Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$)
Table 101. Hospira Recent Development
Table 102. Lonza Group Company Details
Table 103. Lonza Group Business Overview
Table 104. Lonza Group Product
Table 105. Lonza Group Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$)
Table 106. Lonza Group Recent Development
Table 107. Mylan Company Details
Table 108. Mylan Business Overview
Table 109. Mylan Product
Table 110. Mylan Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$)
Table 111. Mylan Recent Development
Table 112. Aurobindo Pharma Business Overview
Table 113. Aurobindo Pharma Product
Table 114. Aurobindo Pharma Company Details
Table 115. Aurobindo Pharma Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$)
Table 116. Aurobindo Pharma Recent Development
Table 117. Dr. Reddy's Laboratories Company Details
Table 118. Dr. Reddy's Laboratories Business Overview
Table 119. Dr. Reddy's Laboratories Product
Table 120. Dr. Reddy's Laboratories Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$)
Table 121. Dr. Reddy's Laboratories Recent Development
Table 122. Actavis Company Details
Table 123. Actavis Business Overview
Table 124. Actavis Product
Table 125. Actavis Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$)
Table 126. Actavis Recent Development
Table 127. Wuxi Apptec Company Details
Table 128. Wuxi Apptec Business Overview
Table 129. Wuxi Apptec Product
Table 130. Wuxi Apptec Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$)
Table 131. Wuxi Apptec Recent Development
Table 132. Zhejiang NHU Company Details
Table 133. Zhejiang NHU Business Overview
Table 134. Zhejiang NHU Product
Table 135. Zhejiang NHU Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$)
Table 136. Zhejiang NHU Recent Development
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type: 2020 VS 2026
Figure 2. Paracetamol Features
Figure 3. Ibuprofen Features
Figure 4. Aspirin Features
Figure 5. Naproxen Features
Figure 6. Others Features
Figure 7. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application: 2020 VS 2026
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Report Years Considered
Figure 12. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Regions: 2020 VS 2026
Figure 14. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Players in 2019
Figure 17. Global Top Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in 2019
Figure 19. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
抗炎症薬の世界市場（～2026年） Market Analysis and Insights: Global Anti-inflammatory Drugs Market The global Anti-inflammatory Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Anti-inflammatory Drugs Scope and Market Size Anti-inflammatory Dru…- バーター症候群治療薬の世界市場（～2026年） Bartter syndrome is a rare genetic disorder that causes specific defects in kidney function. Market Analysis and Insights: Global Bartter Syndrome Drugs Market The global Bartter Syndrome Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% d…
- NSAID治療薬の世界市場（～2026年） Market Analysis and Insights: Global NSAIDs Drug Market The global NSAIDs Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global NSAIDs Drug Scope and Market Size NSAIDs Drug market is segmented by Type, and by Applicati…
- 抗炎症ペプチドの世界市場（～2026年） Anti-inflammatory peptides also known as antiflammins inhibit inflammation of a mammal's skin, lacerations of the musculature, mucous membranes, or injury into the air spaces of the lungs. Anti-inflammatory peptides act by hindering synthesis of platelet-activating factor, neutrophil aggregation and…
- 抗糖尿病治療薬の世界市場（～2026年） The anti-diabetics market includes drugs, which are used for treatment of diabetes mellitus and are also known as oral hypoglycemic/antihyperglycemic agents. The anti-diabetics market has grown tremendously in recent years with increasing prevalence of diabetes mellitus. Thus, systemic therapies for…